Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.
about
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseRespiratory syncytial virus-like nanoparticle vaccination induces long-term protection without pulmonary disease by modulating cytokines and T-cells partially through alveolar macrophages.Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles.Virus-like particle vaccine by intranasal vaccination elicits protective immunity against respiratory syncytial viral infection in mice.Intranasal delivery of Duox2 DNA using cationic polymer can prevent acute influenza A viral infection in vivo lung.Do recombinant-engineered nanoparticle vaccines hold promise for the prevention of respiratory syncytial virus?Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins.
P2860
Q26775152-DE3E604C-A5AF-4D3D-9BEB-27278FE7EEB4Q35867712-B0729EC8-6961-4B2C-8240-5747A3245327Q36202706-EAB76F26-1E9A-4E28-805A-C20B76896A7BQ36207818-ABF88447-7880-4C60-8FAE-6CB187EB06DEQ36739674-DD191859-DE1F-4A35-BA9F-453C3A922D6FQ38921013-E44EFB55-2631-42C8-BF43-4B9BAF3DE67BQ39076542-F5B5ED1D-4A68-4203-BAA7-D6EEF427509EQ40065136-450F6510-6CDA-40B0-8AAF-A382C87E9C2CQ40409972-475A7676-E412-4D05-A881-CB760D1CBD13Q41932352-4305EB38-E041-48E6-B243-6A14F6F757E4Q45338183-898475B1-7F04-4405-999D-B331F77EA6EBQ47137183-BAC77D88-384E-4931-94C6-DA54EB28159B
P2860
Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@ast
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@en
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@nl
type
label
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@ast
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@en
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@nl
prefLabel
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@ast
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@en
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@nl
P2093
P2860
P1476
Virus-like nanoparticle and DN ...... ate and adaptive immune cells.
@en
P2093
Fu-Shi Quan
Hye Suk Hwang
Jae-Min Song
Jong Seok Lee
Martin L Moore
Min Kyoung Cho
Min-Chul Kim
Sang-Moo Kang
Si-Eun Yoo
P2860
P304
P356
10.1016/J.NANO.2014.07.013
P577
2014-08-08T00:00:00Z